Cooper Companies reports Q4 EPS $1.15, consensus $1.11

Reports Q4 revenue $1.07B, consensus $1.06B. “We closed fiscal 2025 ahead of consensus revenue, earnings, and free cash flow expectations, and we enter 2026 with clear priorities to drive long-term shareholder value: accelerating top-line growth, improving profitability, accelerating cash generation, and continuing share repurchases,” said Al White, CooperCompanies’ president and CEO. “CooperVision is building momentum with MyDay contract wins, with MiSight up 37% in Q4, and with upcoming product launches rolling out globally. CooperSurgical also finished the year strong delivering revenue at the high end of our guidance, and we’re optimistic that 2026 will be supported by a much stronger year for our fertility business.”